Clinical Research Directory
Browse clinical research sites, groups, and studies.
Botulinum Toxin Type A Versus Triamcinolone for Facial Myalgia
Sponsor: Riyadh Elm University
Summary
This single-blind randomized controlled trial aims to compare the therapeutic effects of Botulinum Toxin Type A and triamcinolone injections in adults with facial myofascial pain syndrome. A total of 56 participants will be randomly allocated in a 1:1 ratio to receive either Botulinum Toxin Type A or triamcinolone injection. The primary outcome will assess pain intensity using the Visual Analogue Scale (VAS). Secondary outcomes will evaluate headache symptoms and sleep quality. The study aims to determine the comparative effectiveness of the two interventions in reducing pain and improving patient-reported outcomes.
Official title: Comparison of the Therapeutic Effects of Botulinum Toxin Type A and Triamcinolone Injection in Managing Facial Myalgia: A Single Blind Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
56
Start Date
2026-10-11
Completion Date
2026-12-24
Last Updated
2026-10-09
Healthy Volunteers
No
Conditions
Interventions
Botulinum Toxin A (Botox )
Botulinum Toxin Type A will be administered by injection into the affected masticatory muscle trigger points according to the study protocol.
Triamcinolone Acetonide
Triamcinolone acetonide will be administered by injection into the affected masticatory muscle trigger points according to the study protocol.
Locations (1)
Riyadh Elm University
Riyadh, Riyadh Region, Saudi Arabia